Trying hands at bargain stocks that have a low price-to-earnings (P/E) ratio is a common practice. The perception is that the lower the P/E, the higher will be the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run.
But stocks with a rising P/E can also be worth buying. We’ll tell you why this often-overlooked approach may go a long way in picking pick some solid stocks.
SunOpta ( STKL Quick Quote STKL - Free Report) , Casey's General Stores ( CASY Quick Quote CASY - Free Report) , Axcella Health ( AXLA Quick Quote AXLA - Free Report) , Owens & Minor ( OMI Quick Quote OMI - Free Report) and Lazydays Holdings ( LAZY Quick Quote LAZY - Free Report) are some that seem to be winning bets on the parameter of rising P/E. Why Rising P/E a Valuable Tool?
Investors should note that stock price moves in tandem with earnings performance. If earnings come in stronger, the price of a stock shoots up. Solid quarterly earnings and the forward guidance boost earnings forecasts, leading to stronger demand for the stock and an uptrend in its price.
So, if the price is rising steadily, it means that investors are assured of the stock’s fundamental strength and expect some strong positives out of it. Suppose an investor wants to buy a stock with a P/E ratio of 30, it means that he is willing to shell out $30 for only $1 worth of earnings. This is because the investor expects earnings of the company to rise at a faster pace in the future on the back of strong fundamentals.
Also, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.
The Winning Strategy
In order to shortlist stocks that are exhibiting an increasing P/E, we chose the following as our primary screening parameters.
EPS growth estimate for the current year is greater than or equal to last year’s actual growth Percentage change in last year EPS should be greater than or equal to zero
(These two criteria point to flat earnings or a growth trend over the years.)
Percentage change in price over four weeks greater than the percentage change in price over 12 weeks Percentage change in price over 12 weeks greater than percentage change in price over 24 weeks
(These two criteria show that price of the stock is increasing consistently over the said timeframes.)
Percentage price change for four weeks relative to the S&P 500 greater than the percentage price change for 12 weeks relative to the S&P 500 Percentage price change for 12 weeks relative to the S&P 500 greater than the percentage price change for 24 weeks relative to the S&P 500
(Here, the case for consistent price gains gets even stronger as it displays percentage price changes relative to the S&P 500.)
Percentage price change for 12 weeks is 20% higher than or equal to the percentage price change for 24 weeks, but it should not exceed 100%
(A 20% increase in the price of a stock from the breakout point gives cues of an impending uptrend. But a jump of over 100% indicates that there is limited scope for further upside and that the stock might be due for a reversal.)
In addition, we place a few other criteria that lead us to some likely outperformers.
Zacks Rank less than or equal to 2: Only companies with a Zacks Rank #1 (Strong Buy) and Zacks Rank #2 (Buy) can get through. Average 20-day Volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.
Just these few criteria narrowed down the universe from over 7,700 stocks to just 42.
Here are five out of the 42 stocks:
SunOpta: SunOpta Inc. is an operator of high-growth ethical businesses, focusing on integrated business models in the natural and organic food, supplements and health and beauty markets. STKL presently holds a Zacks Rank #2. You can see . the complete list of today’s Zacks #1 Rank stocks here
SunOpta has three business units: the SunOpta Food Group, the Opta Minerals Group, and the SunOpta BioProcess Group.
Casey's General Stores: Casey’s operates convenience stores under the Casey's and Casey's General Store names in 16 Midwestern states, mainly Iowa, Missouri and Illinois. CASY has a Zacks Rank #2 at present.
Casey's General Stores offers a variety of food selection including freshly prepared foods, beverages, tobacco and nicotine products, health and beauty aids, school supplies, houseware, and pet supplies.
Axcella Health: The biotechnology company Axcella Health is engaged in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. AXLA currently carries a Zacks Rank #2.
Axcella Health’s principal candidate consists of AXA1665, AXA1125, AXA1957, AXA2678 and AXA4010 which are in clinical stage.
Owens & Minor: Owens & Minor is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare product. OMI presently Zacks Rank #2.
Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants.
Lazydays Holdings: The Zacks Rank #2 Lazydays Holdings is an iconic brand in the RV industry. LAZY offers RV brands, and features new and pre-owned RVs, service bays and on-site campgrounds.
Lazydays offer RV brands, and features new and pre-owned RVs, service bays and on-site campgrounds. LAZY also has rental fleets in Florida, Arizona and Colorado.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
. Click here to sign up for a free trial to the Research Wizard today Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. Disclosure: Performance information for Zacks’ portfolios and strategies are available at: . https://www.zacks.com/performance